Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females

Mitochondrion

Volumn 7, Issue 1-2, 2007, Pages 72-79

  Nishigaki, Yutaka ^a   Yamada, Yoshiji ^b   Fuku, Noriyuki ^a   Matsuo, Hitoshi ^c   Segawa, Tomonori ^c   Watanabe, Sachiro ^c   Kato, Kimihiko ^d   Yokoi, Kiyoshi ^d   Yamaguchi, Sachiyo ^b   Nozawa, Yoshinori ^e   Tanaka, Masashi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b MIE UNIVERSITY   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^e GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

Author keywords

Atherothrombotic cerebral infarction; Haplogroup A; Mitochondrial genomes; Polymorphisms

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; ASIAN; ATHEROGENESIS; BRAIN INFARCTION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FLUORESCENCE ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CEREBRAL INFARCTION; DNA, MITOCHONDRIAL; FEMALE; HAPLOTYPES; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THROMBOSIS;

EID: 33847671417     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2006.11.002     Document Type: Article

References (25)

1. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., and Young I.G. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
2. Dunbar S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 363 (2006) 71-82
3. Finnila S., Hassinen I.E., and Majamaa K. Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke. Evaluation of mutations by using sequence data on the entire coding region. Mutat. Res. 458 (2001) 31-39
4. Fuku N., Oshida Y., Takeyasu T., Guo L.J., Kurata M., Yamada Y., Sato Y., and Tanaka M. Mitochondrial ATPase subunit 6 and cytochrome B gene polymorphisms in young obese adults. Biochem. Biophys. Res. Commun. 290 (2002) 1199-1205
5. Fuku, N., Park, K.S., Yamada, Y., Nishigaki, Y., Cho, Y.M., Matsuo, H., Segawa, T., Watanabe, S., Kato, K., Yokoi, K., Nozawa, Y., Lee, H.K., Tanaka, M. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am. J. Hum. Genet., in press.
6. Grantham R. Amino acid difference formula to help explain protein evolution. Science 185 (1974) 862-864
7. Guo L.J., Oshida Y., Fuku N., Takeyasu T., Fujita Y., Kurata M., Sato Y., Ito M., and Tanaka M. Mitochondrial genome polymorphisms associated with type 2 diabetes or obesity. Mitochondrion 5 (2005) 15-33
8. Holt I.J., Harding A.E., Petty R.K., and Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46 (1990) 428-433
9. Humphries S.E., and Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet. Neurol. 3 (2004) 227-235
10. Ikebe S., Tanaka M., and Ozawa T. Point mutations of mitochondrial genome in Parkinson's disease. Brain. Res. Mol. Brain. Res. 28 (1995) 281-295
11. Itoh Y., Mizuki N., Shimada T., Azuma F., Itakura M., Kashiwase K., Kikkawa E., Kulski J.K., Satake M., and Inoko H. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57 (2005) 717-729
12. Kimura K., Kazui S., Minematsu K., and Yamaguchi T. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc. Dis. 18 (2004) 47-56
13. Kitamura A., Nakagawa Y., Sato M., Iso H., Sato S., Imano H., Kiyama M., Okada T., Okada H., Iida M., and Shimamoto T. Proportions of stroke subtypes among men and women ≥40 years of age in an urban Japanese city in 1992, 1997, and 2002. Stroke 37 (2006) 1374-1378
14. Koh K.K. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc. Res. 55 (2002) 714-726
15. Kubo M., Kiyohara Y., Ninomiya T., Tanizaki Y., Yonemoto K., Doi Y., Hata J., Oishi Y., Shikata K., and Iida M. Decreasing incidence of lacunar vs. other types of cerebral infarction in a Japanese population. Neurology 66 (2006) 1539-1544
16. Liou C.W., Lin T.K., Huang F.M., Chen T.L., Lee C.F., Chuang Y.C., Tan T.Y., Chang K.C., and Wei Y.H. Association of the mitochondrial DNA 16189 T to C variant with lacunar cerebral infarction: evidence from a hospital-based case-control study. Ann. NY. Acad. Sci. 1011 (2004) 317-324
17. Majamaa K., Finnila S., Turkka J., and Hassinen I.E. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet 352 (1998) 455-456
18. Martinez-Fernandez E., Gil-Peralta A., Garcia-Lozano R., Chinchon I., Aguilera I., Fernandez-Lopez O., Arenas J., Campos Y., and Bautista J. Mitochondrial disease and stroke. Stroke 32 (2001) 2507-2510
19. Morgan L., and Humphries S.E. The genetics of stroke. Curr. Opin. Lipidol. 16 (2005) 193-199
20. Pakendorf B., and Stoneking M. Mitochondrial DNA and human evolution. Annu. Rev. Genomics. Hum. Genet. 6 (2005) 165-183
21. Special report from the National Institute of Neurological Disorders and Stroke. 1990. The Classification of Cerebrovascular Diseases III. Stroke. 21, pp. 637-676.
22. Tanaka M., Gong J.S., Zhang J., Yoneda M., and Yagi K. Mitochondrial genotype associated with longevity. Lancet 351 (1998) 185-186
23. Tanaka M., Borgeld H.J., Zhang J., Muramatsu S., Gong J.S., Yoneda M., Maruyama W., Naoi M., Ibi T., Sahashi K., Shamoto M., Fuku N., Kurata M., Yamada Y., Nishizawa K., Akao Y., Ohishi N., Miyabayashi S., Umemoto H., Muramatsu T., Furukawa K., Kikuchi A., Nakano I., Ozawa K., and Yagi K. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J. Biomed. Sci. 9 (2002) 534-541
24. Tanaka M., Cabrera V.M., Gonzalez A.M., Larruga J.M., Takeyasu T., Fuku N., Guo L.J., Hirose R., Fujita Y., Kurata M., Shinoda K., Umetsu K., Yamada Y., Oshida Y., Sato Y., Hattori N., Mizuno Y., Arai Y., Hirose N., Ohta S., Ogawa O., Tanaka Y., Kawamori R., Shamoto-Nagai M., Maruyama W., Shimokata H., Suzuki R., and Shimodaira H. Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome. Res. 14 (2004) 1832-1850
25. Tanaka, M., Fuku, N., Nishigaki, Y., Matsuo, H., Segawa, T., Watanabe, S., Kato, K., Yokoi, K., Yamaguchi, S., Nozawa, Y., Yamada, Y. Women with mitochondrial haplogroup N9a are protected against metabolic syndrome. Diabetes, in press.